These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 239560)
1. Further virological and clinical investigations on the attenuated E5"14" virus from the tick-borne excephalitis complex. Mayer V; Pogády J; Orolin D; Stárek M; Hudecová M; Buran J; Hrbka G Acta Virol; 1975 Apr; 19(2):143-9. PubMed ID: 239560 [TBL] [Abstract][Full Text] [Related]
2. A live vaccine against tick-born encephalitis: integrated studies. III. Response of man to a single dose of the E5 "14" clone (Langat virus). Mayer V; Pogády J; Starek M; Hrbka J Acta Virol; 1975 May; 19(3):229-36. PubMed ID: 239578 [TBL] [Abstract][Full Text] [Related]
3. Experimental live tick-borne encephalitis vaccine (Labgat E5 "14" virus clone): volunteers 1 and 2 years after single-dose immunization. Mayer V; Orolin D; Pogády J; Stárek M; Kubistová K; Gajdosová E; Buran I Acta Virol; 1976 Jun; 20(3):215-25. PubMed ID: 9802 [TBL] [Abstract][Full Text] [Related]
4. Humoral antibody response in volunteers given the live, highly attenuated "14" clone derived from Langat E5 virus. Mayer V Acta Virol; 1973 Jul; 17(4):367. PubMed ID: 4148224 [No Abstract] [Full Text] [Related]
5. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3' deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice. Pletnev AG Virology; 2001 Apr; 282(2):288-300. PubMed ID: 11289811 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of tick-borne encephalitis DNA vaccines in monkeys. Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091 [TBL] [Abstract][Full Text] [Related]
7. A live vaccine against tick-borne encephalitis: integrated studies. I. Basic properties and behaviour of the E5 "14" Clone (Langat virus). Mayer V Acta Virol; 1975 May; 19(3):209-18. PubMed ID: 239576 [TBL] [Abstract][Full Text] [Related]
8. Long-term persistence of cell-mediated and humoral immune response in specifically resistant mice given live attenuated langat (E5 "14") virus. Gajdosová E; Mayer V Acta Virol; 1978 Mar; 22(2):131-8. PubMed ID: 26198 [TBL] [Abstract][Full Text] [Related]
9. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis. Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392 [TBL] [Abstract][Full Text] [Related]
10. [Immunological aspects in studying attenuated strains of the tick-borne encephalitis virus complex]. Levkovich EN; Karpovich LG; Sharmukhamedova DA; Mamonenko LL Vestn Akad Med Nauk SSSR; 1977; (5):21-8. PubMed ID: 70125 [No Abstract] [Full Text] [Related]
11. Immune response to different tick-borne encephalitis vaccines as revealed by lymphocyte blast transformation and virus neutralization tests. Dzagurov SG; Vorobieva MS; Shalamberidze TD; Karpovich LG; Blokha VV; Bukovskaya NS Acta Virol; 1984 Sep; 28(5):388-94. PubMed ID: 6151352 [TBL] [Abstract][Full Text] [Related]
12. Studies on the immunizing potency of tick-borne encephalitis vaccines. Gall W Acta Microbiol Pol A; 1973; 5(3):279-85. PubMed ID: 4769562 [No Abstract] [Full Text] [Related]
13. [Effect of a natural interferon inducer (RFf2) on the formation of vaccinal immunity to tick-borne encephalitis]. Fomina AN; Nosik NN; Bukata LA; Davydova AA; Barinskiĭ NF Antibiotiki; 1979 Jan; 24(1):67-71. PubMed ID: 426497 [TBL] [Abstract][Full Text] [Related]
15. Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time intervals to primary immunization with the rapid schedule. Schöndorf I; Schönfeld C; Nicolay U; Zent O; Banzhoff A Int J Med Microbiol; 2006 May; 296 Suppl 40():208-12. PubMed ID: 16531118 [TBL] [Abstract][Full Text] [Related]
16. Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination. Kleiter I; Jilg W; Bogdahn U; Steinbrecher A Infection; 2007 Feb; 35(1):26-9. PubMed ID: 17297586 [TBL] [Abstract][Full Text] [Related]
17. A live vaccine against tick-borne encephalitis; integrated studies, H. Histopathology of mice peripherally immunized with E5 "14" virus and challenged with virulent virus. Mitrová E; Mayer V Acta Virol; 1975 May; 19(3):219-28. PubMed ID: 239577 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies to tick-borne encephalitis (TBE) virus: their use for differentiation of the TBE complex viruses. Kopecký J; Tomková E; Grubhoffer L; Melnikova YE Acta Virol; 1991 Aug; 35(4):365-72. PubMed ID: 1686961 [TBL] [Abstract][Full Text] [Related]
19. In vitro studies on cell-mediated immune response to tick-borne encephalitis virus: findings in convalescents and human subclinical infections. Mayer V; Gajdosová E; Slávik I Acta Virol; 1976 Oct; 20(5):395-401. PubMed ID: 11667 [TBL] [Abstract][Full Text] [Related]
20. [Decreased humoral immunity to the tick-borne encephalitis virus in the population of the western Urals]. Kuziaev RZ; Iaroshenko LK; Minaeva VM; Gusmanova AK; Korzukhina LF; Mironova TV Med Parazitol (Mosk); 1992; (1):37-9. PubMed ID: 1387192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]